SCHEMBL19821391

SCHEMBL19821391

C#CCCC(=O)OCCOCCOCCC

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.44
EPHX2 P34913 2/20 0.35
ALDH1A1 P00352 3/20 0.34
TSHR P16473 2/20 0.34
ADRA2A P08913 1/20 0.34
ADRA1A P35348 1/20 0.34
DNM1 Q05193 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CNR1 P21554 2/20 0.34
CNR2 P34972 1/20 0.34
MAPT P10636 1/20 0.33
BLM P54132 1/20 0.33
HTR2C P28335 1/20 0.33
GLA P06280 1/20 0.33
NAAA Q02083 1/20 0.32
GSTP1 P09211 1/20 0.31
TDP1 Q9NUW8 2/20 0.31
HSD17B10 Q99714 1/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6418312 0.91 DGKA (0.38) DGKAEPHX2ALDH1A1TSHRADRA2A
SCHEMBL10124124 0.89 DGKA (0.45) DGKAALDH1A1ADRA2AADRA1ADNM1
SCHEMBL19821373 0.86 DGKA (0.36) DGKAALDH1A1TSHRADRA2AADRA1A
SCHEMBL6420417 0.84 DGKA (0.41) DGKAALDH1A1TSHRADRA2AADRA1A
SCHEMBL17871681 0.82 DGKA (0.56) DGKAEPHX2ALDH1A1TSHRADRA2A
SCHEMBL6105192 0.81 DGKA (0.52) DGKAALDH1A1TSHRDNM1L3MBTL1
SCHEMBL29253805 0.81 DGKA (0.54) DGKAEPHX2ALDH1A1TSHRADRA2A
SCHEMBL2249107 0.81 DGKA (0.54) DGKAEPHX2ALDH1A1TSHRADRA2A
SCHEMBL17871685 0.79 DGKA (0.69) DGKAEPHX2ALDH1A1TSHRDNM1
SCHEMBL27710496 0.79 DGKA (0.63) DGKAEPHX2ALDH1A1TSHRADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180147298-A1 COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS MODERNATX, INC. (US) 2018-05-31 US disclosed
US-20180028664-A1 COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS MODERNATX, INC. (US) 2018-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180147298-A1 COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS HDLBP, APOB, TSG101 DGKA 1381/4885EPHX2 2965/4885ALDH1A1 3952/4885
US-20180028664-A1 COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS HDLBP, APOB, TSG101 DGKA 1381/4885EPHX2 2965/4885ALDH1A1 3952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.